{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T23:25:26Z","timestamp":1784589926985,"version":"3.55.0"},"reference-count":10,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,12,16]]},"DOI":"10.7759\/cureus.20452","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T08:59:18Z","timestamp":1639645158000},"source":"Crossref","is-referenced-by-count":1,"title":["Severe Hypophosphatemia Following Ferric Carboxymaltose in a Patient With Inflammatory Bowel Disease"],"prefix":"10.7759","author":[{"given":"Abuobeida","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Elmdaah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed Mohammed","family":"Mustafa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aravind Sunderavel","family":"Kumaravel Kanagavelu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nader","family":"Mohamed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saber","family":"Sayed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Haemoglobin concentrations for the diagnosis of anaemia and assessment of severity. (2011). Accessed. August 12, 2021: https:\/\/www.who.int\/vmnis\/indicators\/haemoglobin.pdf."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MNH.0000000000000329","article-title":"Iron-induced hypophosphatemia: an emerging complication","volume":"26","author":"Zoller H","year":"2017","unstructured":"Zoller H, Schaefer B, Glodny B. Iron-induced hypophosphatemia: an emerging complication. Curr Opin Nephrol Hypertens. 2017, 26:266-75. 10.1097\/MNH.0000000000000329","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2016-219160","article-title":"Severe hypophosphataemia after intravenous iron administration","volume":"2017","author":"Anand G","year":"2017","unstructured":"Anand G, Schmid C. Severe hypophosphataemia after intravenous iron administration. BMJ Case Rep. 2017, 2017:10.1136\/bcr-2016-219160","journal-title":"BMJ Case Rep"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1258\/acb.2008.008151","article-title":"Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia","volume":"46","author":"Schouten BJ","year":"2009","unstructured":"Schouten BJ, Doogue MP, Soule SG, Hunt PJ. Iron polymaltose-induced FGF23 elevation complicated by hypophosphataemic osteomalacia. Ann Clin Biochem. 2009, 46:167-9. 10.1258\/acb.2008.008151","journal-title":"Ann Clin Biochem"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2009.02327.x","article-title":"Blood Management: large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial","volume":"49","author":"Van Wyck DB","year":"2009","unstructured":"Van Wyck DB, Mangione A, Morrison J, Hadley PE, Jehle JA, Goodnough LT. Blood Management: large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. 2009, 49:2719-28. 10.1111\/j.1537-2995.2009.02327.x","journal-title":"Transfusion"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1155\/2015\/468675","article-title":"Intravenous iron administration and hypophosphatemia in clinical practice","volume":"2015","author":"Hardy S","year":"2015","unstructured":"Hardy S, Vandemergel X. Intravenous iron administration and hypophosphatemia in clinical practice. Int J Rheumatol. 2015, 2015:10.1155\/2015\/468675","journal-title":"Int J Rheumatol"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.3319","article-title":"Hypophosphatemia, severe bone pain, gait disturbance, and fatigue fractures after iron substitution in inflammatory bowel disease: a case report","volume":"33","author":"Bartko J","year":"2018","unstructured":"Bartko J, Roschger P, Zandieh S, Brehm A, Zwerina J, Klaushofer K. Hypophosphatemia, severe bone pain, gait disturbance, and fatigue fractures after iron substitution in inflammatory bowel disease: a case report. J Bone Miner Res. 2018, 33:534-9. 10.1002\/jbmr.3319","journal-title":"J Bone Miner Res"},{"key":"ref8","doi-asserted-by":"crossref","DOI":"10.52964\/AMJA.0809","article-title":"Ferric carboxymaltose (Ferinject\u00ae) associated hypophosphataemia: case report illustrating the need for increased awareness to minimise incidence and risk","volume":"19","author":"Fisher S","year":"2020","unstructured":"Fisher S, Jonker L. Ferric carboxymaltose (Ferinject\u00ae) associated hypophosphataemia: case report illustrating the need for increased awareness to minimise incidence and risk. Acute Med. 2020, 19:102-5.","journal-title":"Acute Med"},{"key":"ref9","article-title":"Severe hypophosphataemia after intravenous iron administration","volume":"72","author":"Blazevic A","year":"2014","unstructured":"Blazevic A, Hunze J, Boots JM. Severe hypophosphataemia after intravenous iron administration. Neth J Med. 2014, 72:49-53.","journal-title":"Neth J Med"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1172\/JCI18399","article-title":"FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting","volume":"112","author":"Riminucci M","year":"2003","unstructured":"Riminucci M, Collins MT, Fedarko NS, et al.. FGF-23 in fibrous dysplasia of bone and its relationship to renal phosphate wasting. J Clin Invest. 2003, 112:683-92. 10.1172\/JCI18399","journal-title":"J Clin Invest"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/78959-severe-hypophosphatemia-following-ferric-carboxymaltose-in-a-patient-with-inflammatory-bowel-disease","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:34:01Z","timestamp":1707507241000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/78959-severe-hypophosphatemia-following-ferric-carboxymaltose-in-a-patient-with-inflammatory-bowel-disease"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12,16]]},"references-count":10,"URL":"https:\/\/doi.org\/10.7759\/cureus.20452","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12,16]]}}}